Marc Rogers

1.4k total citations
26 papers, 974 citations indexed

About

Marc Rogers is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marc Rogers has authored 26 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marc Rogers's work include Ion channel regulation and function (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Nicotinic Acetylcholine Receptors Study (6 papers). Marc Rogers is often cited by papers focused on Ion channel regulation and function (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Nicotinic Acetylcholine Receptors Study (6 papers). Marc Rogers collaborates with scholars based in United States, United Kingdom and Slovenia. Marc Rogers's co-authors include John A. Dani, Alan D. Guerci, Nisha C. Chandra, Raymond C. Koehler, J E Tsitlik, Richard J. Traystman, Myron L. Weisfeldt, E. Niedermeyer, David J. Madge and Edward B. Stevens and has published in prestigious journals such as Circulation, Journal of Neurophysiology and FEBS Letters.

In The Last Decade

Marc Rogers

23 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Rogers United States 13 448 283 220 210 195 26 974
Sean Scott Australia 10 189 0.4× 150 0.5× 197 0.9× 55 0.3× 74 0.4× 16 925
Keith A. Collins United States 19 110 0.2× 322 1.1× 345 1.6× 452 2.2× 296 1.5× 44 1.2k
David P. Hall United States 15 87 0.2× 172 0.6× 176 0.8× 235 1.1× 145 0.7× 34 821
Dagoberto Soto Chile 16 129 0.3× 338 1.2× 108 0.5× 171 0.8× 167 0.9× 40 820
Stephen R. Shorofsky United States 32 116 0.3× 609 2.2× 92 0.4× 2.3k 10.8× 253 1.3× 116 2.6k
Luc Heytens Belgium 20 41 0.1× 529 1.9× 43 0.2× 434 2.1× 167 0.9× 55 973
R Krivosic-Horber France 17 48 0.1× 689 2.4× 35 0.2× 678 3.2× 161 0.8× 98 1.3k
Jelle R. de Kruijk Netherlands 11 308 0.7× 213 0.8× 40 0.2× 33 0.2× 30 0.2× 17 906
John J. Tomasula United States 13 207 0.5× 138 0.5× 26 0.1× 38 0.2× 155 0.8× 16 931
Jackson H. Stuckey United States 22 133 0.3× 147 0.5× 166 0.8× 1.2k 5.7× 99 0.5× 60 1.5k

Countries citing papers authored by Marc Rogers

Since Specialization
Citations

This map shows the geographic impact of Marc Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Rogers more than expected).

Fields of papers citing papers by Marc Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Rogers. The network helps show where Marc Rogers may publish in the future.

Co-authorship network of co-authors of Marc Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Rogers. A scholar is included among the top collaborators of Marc Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Rogers. Marc Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zidar, Nace, Tihomir Tomašič, D. Kikelj, et al.. (2023). New aryl and acylsulfonamides as state-dependent inhibitors of Nav1.3 voltage-gated sodium channel. European Journal of Medicinal Chemistry. 258. 115530–115530. 2 indexed citations
2.
Ridley, John, et al.. (2022). Development of ASIC1a ligand-gated ion channel drug screening assays across multiple automated patch clamp platforms. Frontiers in Molecular Neuroscience. 15. 982689–982689. 3 indexed citations
3.
Rogers, Marc, et al.. (2021). Development and Validation of ASIC1a Ligand-Gated Ion Channel Drug Discovery Assays on Automated Patch Clamp Platforms. Biophysical Journal. 120(3). 338a–338a. 1 indexed citations
4.
Rogers, Marc, et al.. (2021). Validation of an ASIC1a Ligand-Gated Assay on an Automated Patch Clamp Platform and its Use for Novel Ligand Screening. Biophysical Journal. 120(3). 337a–337a. 1 indexed citations
5.
6.
Egawa, Nagayasu, Robin Crawford, Marc Rogers, et al.. (2021). Dynamics of papillomavirus in vivo disease formation & susceptibility to high-level disinfection—Implications for transmission in clinical settings. EBioMedicine. 63. 103177–103177. 20 indexed citations
7.
8.
Williams, Sarah, et al.. (2018). Comprehensive profiling of axiogenesis ventricular vCor.4U iPSC-derived cardiomyocytes—From electrophysiology to phenotypic assays. Journal of Pharmacological and Toxicological Methods. 93. 167–168.
9.
Zidar, Nace, Tihomir Tomašič, Marc Rogers, et al.. (2017). Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of the voltage-gated potassium channels. European Journal of Medicinal Chemistry. 139. 232–241. 13 indexed citations
10.
11.
Ford, John W., J. Milnes, Erich Wettwer, et al.. (2013). Human Electrophysiological and Pharmacological Properties of XEN-D0101. Journal of Cardiovascular Pharmacology. 61(5). 408–415. 39 indexed citations
12.
Rolland, Jean‐François, David J. Madge, John W. Ford, & Marc Rogers. (2009). Biophysical Characterization Of Duloxetine Activity On Voltage-gated Sodium Channels Involved In Pain Transmission. Biophysical Journal. 96(3). 252a–252a. 1 indexed citations
13.
Milnes, James T., Laurence Louis, Marc Rogers, David J. Madge, & John W. Ford. (2008). Abstract 1519: The Atrial Antiarrhythmic Drug XEN-D0101 Selectively Inhibits the Human Ultra-Rapid Delayed-Rectifier Potassium Current (IKur) Over Other Cardiac Ion Channels. Circulation. 118. 4 indexed citations
14.
Rogers, Marc, et al.. (2006). The role of sodium channels in neuropathic pain. Seminars in Cell and Developmental Biology. 17(5). 571–581. 103 indexed citations
15.
Rogers, Marc & Peter B. Sargent. (2003). Rapid activation of presynaptic nicotinic acetylcholine receptors by nerve‐released transmitter. European Journal of Neuroscience. 18(11). 2946–2956. 6 indexed citations
16.
Passafaro, Maria, et al.. (2000). MODULATION OF N-TYPE CALCIUM CHANNELS TRANSLOCATION IN RINm5F INSULINOMA CELLS. Pharmacological Research. 41(3). 325–334. 7 indexed citations
17.
Sher, Emanuele, Agnese Codignola, Marc Rogers, & Janet E. Richmond. (1996). Noradrenaline inhibition of Ca2+ channels and secretion in single patch‐clamped insulinoma cells. FEBS Letters. 385(3). 176–180. 7 indexed citations
18.
Rogers, Marc & John A. Dani. (1995). Comparison of quantitative calcium flux through NMDA, ATP, and ACh receptor channels. Biophysical Journal. 68(2). 501–506. 136 indexed citations
19.
Rogers, Marc & Ian A. Hendry. (1990). Involvement of dihydropyridine‐sensitive calcium channels in nerve growth factor‐dependent neurite outgrowth by sympathetic neurons. Journal of Neuroscience Research. 26(4). 447–454. 20 indexed citations
20.
Rogers, Marc, et al.. (1986). PERSISTANCE OF CEREBRAL BLOOD FLOW AUTOREGULATION DURING NITROPRUSSIDE ADMINISTRATION.. Anesthesiology. 65(Supplement). A574–A574. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sean Scott Breakdown of academic impact, for papers by Keith A. Collins Breakdown of academic impact, for papers by David P. Hall Breakdown of academic impact, for papers by Dagoberto Soto Breakdown of academic impact, for papers by Stephen R. Shorofsky Breakdown of academic impact, for papers by Luc Heytens Breakdown of academic impact, for papers by R Krivosic-Horber Breakdown of academic impact, for papers by Jelle R. de Kruijk Breakdown of academic impact, for papers by John J. Tomasula Breakdown of academic impact, for papers by Jackson H. Stuckey
Rankless by CCL
2026